Adam Scott Levy, CFO and Secretary at Mineralys Therapeutics, Inc. (MLYS), sold 194,991 shares at $45.93 ($8.7M) on 2025-11-11, disclosed to the SEC on 2025-11-13.
Open-market sale of $8.7M MLYS by CFO and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.65 | 12,952 | $539K | 6.2% |
| 2 | $41.65 | 12,952 | $539K | 6.2% |
| 3 | $41.87 | 11,295 | $473K | 5.4% |
| 4 | $41.87 | 11,295 | $473K | 5.4% |
| 5 | $42.00 | 1,015 | $43K | 0.5% |
| 6 | $42.34 | 8,485 |
| $359K |
| 4.1% |
| 7 | $42.34 | 8,485 | $359K | 4.1% |
| 8 | $42.68 | 1,561 | $67K | 0.8% |
| 9 | $42.68 | 1,561 | $67K | 0.8% |
| 10 | $43.50 | 4,142 | $180K | 2.1% |
| 11 | $45.18 | 8,456 | $382K | 4.4% |
| 12 | $45.18 | 8,456 | $382K | 4.4% |
| 13 | $45.93 | 38,900 | $1.8M | 20.5% |
| 14 | $46.88 | 32,718 | $1.5M | 17.6% |
| 15 | $46.88 | 32,718 | $1.5M | 17.6% |
| Total | $44.71 avg | 194,991 | $8.7M | 100% |
| Filing → |
| MLYS | SELL | 2025-07-30 | $1.4M | — | Filing → |
| MLYS | SELL | 2025-07-15 | $311K | — | Filing → |
| MLYS | SELL | 2025-04-15 | $259K | — | Filing → |